A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial

Publication date: Available online 10 October 2020Source: American Heart JournalAuthor(s): Helio P. Guimarães, Pedro G.M. de Barros e Silva, Idelzuita L. Liporace, Roney O. Sampaio, Flávio Tarasoutchi, Milena Paixão, Conrado R. Hoffmann-Filho, Rodrigo Patriota, Tiago L.L. Leiria, Diana Lamprea, Dalton B. Precoma, Fernando A. Atik, Fabio S. Silveira, Fabio R. Farias, Diogo O. Barreto, Adail P. Almeida, Alexandre C. Zilli, João D. de Souza Neto, Margaret A. Cavalcante, Fernando A.M.S. Figueira
Source: American Heart Journal - Category: Cardiology Source Type: research